Latest Study on CRISPR Gene Editing Market – Analysis of Industry Current Growth Rate, Size, Share and Projection for the Next 7 Years

Market Overview: CRISPR Gene Editing Market

MarkNtel Advisors, leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. Recently published a report on CRISPR Gene Editing Market and provide your business with the latest market trends and analysis from our reports to make informed decisions and stay ahead of the competition.

CRISPR Gene Editing Market Insights 2022-27

The CRISPR Gene Editing Market is estimated to grow at a CAGR of around 18.24% during the forecast period 2022-27.

Request Sample Report – https://www.marknteladvisors.com/query/request-sample/crispr-gene-editing-market.html

Driving Innovation: Exploring the CRISPR Gene Editing Market and its Key Driver

Key Driver: Prevalence of Genetic Disorders & Use of Genome Editing to Boost the Market Growth

The prevalence of genetic disorders has been increasing over the years across the globe. Some of the most prevalent are thalassemia, down syndrome, cystic fibrosis, and sickle cell anemia. For every 10,000 live births globally, 4.4 cases of thalassemia are reported. According to the Thalassemia International Federation, about 7% of the population experience hemoglobin-associated conditions, around 70% have sickle cell anemia, and the remaining develop thalassemia or other blood disorders.

Further, in recent years, CRISPR gene editing demand has been driven by significant breakthrough scientific research across various dimensions to treat hereditary disorders. As per the research publication of the New England Journal of Medicine, 2020, CRISPR gene therapies depicted positive results for treating sickle cell anemia & beta-thalassemia. In addition, ongoing clinical trials for the gene correction in homo sapiens to treat genetic disorders further augmented the growth of the CRISPR Gene Editing market globally. For instance:

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease (CEDAR) clinical trial was posted in the USA, as of 2021, which is considered a first-in-human, single-arm study. The study is currently in Phase1/11 & is expected to be completed in 2026.

Top Players in the CRISPR Gene Editing Market:

-Abcam Inc.

-Applied StemCell Inc.

-Agilent Technologies Inc.

-Cellecta Inc.

-CRISPR Therapeutics AG

-Thermo Fischer Scientific Inc.

-GeneCopoeia Inc.

-GeneScript Biotech Corporation

-Horizon Discovery Group PLC

-Integrated DNA Technologies Inc.

Recent Developments by the Leading Companies

• In April 2021, Abbott Laboratories, Inc. launched a coronary imaging platform, Ultreon 1.0 Software, in Europe, i.e., powered by technologies like Artificial Intelligence (AI). The software is built mainly to improve the detection process for calcium-based blockages & measure vessel diameter in the coronary stenting procedures.

Read Full Report -  https://www.marknteladvisors.com/research-library/crispr-gene-editing-market.html

Segmentation Analysis of CRISPR Gene Editing Market

CRISPR Gene Editing Market exactly assesses and highlights significant trends and influencing factors within each segment. The comprehensive analysis extends its predictions for the period spanning 2022-27, focusing on the national landscape. The market is exactly categorized based on this analysis, providing valuable insights into its various facets.

By Product Type

-CRISPR Products

–Kits & Enzymes

–Libraries

–Design Tools

–Antibodies

–Others

-CRISPR Services

–gRNA Design & Vector Construction

–Cell Line and Engineering

–Screening Services

–Others

• Here, the CRISPR Products type dominates the Global CRISPR Gene Editing market and is anticipated to remain dominant during the forecast period

By Application

-Agriculture

-Industrial

-Biomedical

–Gene Therapy

–Drug Discovery

–Diagnostics

-Others

By End User

-Academic Institutions and Research Centers

-Biotechnology Companies

-Contract Research Organizations (CROs)

-Pharmaceutical & Biopharmaceutical Companies

Request Customization –  https://www.marknteladvisors.com/query/request-customization/crispr-gene-editing-market.html                       

A Comprehensive Geographical Analysis:

By Region

-North America

-Latin America

-Europe

-Middle East & Africa

-Asia-Pacific

• Of all the regions, North America is home to many legacies & emerging companies in the field of CRISPR gene editing that are currently investigating drug candidates in clinical research.

Why Choose Us?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Being one of the most efficient market research companies in India, our specialized team of experienced & efficient market research professionals is capable of grasping every minute and valuable information & data of the market to offer our clients with satisfactory details. Our company has served the biggest market research firms in India at leading positions and is proficient in managing all types of market research projects.

About Us

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Reach us:

Call: +1 628 895 8081, +91 120 4278433

Email: [email protected]

Visit to know more:  www.marknteladvisors.com